Pia Aehnlich

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.

Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.

Journal: Molecular oncology
Published: December 13, 2025

Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cells.

Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cells.

Journal: Immuno-oncology technology
Published: April 24, 2025

AXL Tyrosine Kinases: A Growing Isoform Family That Promotes Cancer Pathogenesis.

AXL Tyrosine Kinases: A Growing Isoform Family That Promotes Cancer Pathogenesis.

Journal: Cancer research
Published: October 21, 2024

AXL in myeloid malignancies - an elusive target?

AXL in myeloid malignancies - an elusive target?

Journal: Biomarker research
Published: September 25, 2024

Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapy.

Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapy.

Journal: Cytotherapy
Published: September 13, 2023

Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression.

Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression.

Journal: Frontiers in immunology
Published: June 15, 2022

Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression.

Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression.

Journal: Frontiers in immunology
Published: January 31, 2022

Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8+ T Cells.

Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8+ T Cells.

Journal: Vaccines
Published: September 28, 2021

Mitochondrial-Linked De Novo Pyrimidine Biosynthesis Dictates Human T-Cell Proliferation but Not Expression of Effector Molecules.

Mitochondrial-Linked De Novo Pyrimidine Biosynthesis Dictates Human T-Cell Proliferation but Not Expression of Effector Molecules.

Journal: Frontiers in immunology
Published: June 01, 2021

TAM Receptor Inhibition-Implications for Cancer and the Immune System.

TAM Receptor Inhibition-Implications for Cancer and the Immune System.

Journal: Cancers
Published: February 20, 2021

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens.

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens.

Journal: Frontiers in immunology
Published: December 22, 2020

The capacity of CD4+ Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56.

The capacity of CD4+ Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56.

Journal: Cytotherapy
Published: October 08, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026